These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1052 related items for PubMed ID: 18313835

  • 21. 11Beta-hydroxysteroid dehydrogenase type 1 in human disease: a novel therapeutic target.
    Tomlinson JW.
    Minerva Endocrinol; 2005 Mar; 30(1):37-46. PubMed ID: 15877012
    [Abstract] [Full Text] [Related]

  • 22. Cell-based assay for screening 11beta-hydroxysteroid dehydrogenase 1 inhibitors.
    Cho YS, Kim CH, Cheon HG.
    Anal Biochem; 2009 Sep 15; 392(2):110-6. PubMed ID: 19497289
    [Abstract] [Full Text] [Related]

  • 23. 11β-Hydroxysteroid dehydrogenase 1 contributes to the pro-inflammatory response of keratinocytes.
    Itoi S, Terao M, Murota H, Katayama I.
    Biochem Biophys Res Commun; 2013 Oct 18; 440(2):265-70. PubMed ID: 24055708
    [Abstract] [Full Text] [Related]

  • 24. Characterisation of the prereceptor regulation of glucocorticoids in the anterior segment of the rabbit eye.
    Onyimba CU, Vijapurapu N, Curnow SJ, Khosla P, Stewart PM, Murray PI, Walker EA, Rauz S.
    J Endocrinol; 2006 Aug 18; 190(2):483-93. PubMed ID: 16899581
    [Abstract] [Full Text] [Related]

  • 25. 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action.
    Seckl JR.
    Curr Opin Pharmacol; 2004 Dec 18; 4(6):597-602. PubMed ID: 15525550
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target.
    Wamil M, Seckl JR.
    Drug Discov Today; 2007 Jul 18; 12(13-14):504-20. PubMed ID: 17631244
    [Abstract] [Full Text] [Related]

  • 27. Differential expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 mRNA and glucocorticoid receptor protein during mouse embryonic development.
    Thompson A, Han VK, Yang K.
    J Steroid Biochem Mol Biol; 2004 Apr 18; 88(4-5):367-75. PubMed ID: 15145446
    [Abstract] [Full Text] [Related]

  • 28. Recent advances in the discovery of 11beta-HSD1 inhibitors.
    Boyle CD.
    Curr Opin Drug Discov Devel; 2008 Jul 18; 11(4):495-511. PubMed ID: 18600567
    [Abstract] [Full Text] [Related]

  • 29. 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?
    Anagnostis P, Katsiki N, Adamidou F, Athyros VG, Karagiannis A, Kita M, Mikhailidis DP.
    Metabolism; 2013 Jan 18; 62(1):21-33. PubMed ID: 22652056
    [Abstract] [Full Text] [Related]

  • 30. Glucocorticoid-mediated effects on metabolism are reversed by targeting 11 beta hydroxysteroid dehydrogenase type 1 in human skeletal muscle.
    Salehzadeh F, Al-Khalili L, Kulkarni SS, Wang M, Lönnqvist F, Krook A.
    Diabetes Metab Res Rev; 2009 Mar 18; 25(3):250-8. PubMed ID: 19222059
    [Abstract] [Full Text] [Related]

  • 31. 11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice.
    Hermanowski-Vosatka A, Balkovec JM, Cheng K, Chen HY, Hernandez M, Koo GC, Le Grand CB, Li Z, Metzger JM, Mundt SS, Noonan H, Nunes CN, Olson SH, Pikounis B, Ren N, Robertson N, Schaeffer JM, Shah K, Springer MS, Strack AM, Strowski M, Wu K, Wu T, Xiao J, Zhang BB, Wright SD, Thieringer R.
    J Exp Med; 2005 Aug 15; 202(4):517-27. PubMed ID: 16103409
    [Abstract] [Full Text] [Related]

  • 32. Cortisol--cause and cure for metabolic syndrome?
    Walker BR.
    Diabet Med; 2006 Dec 15; 23(12):1281-8. PubMed ID: 17116176
    [Abstract] [Full Text] [Related]

  • 33. 11beta-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory.
    Seckl JR, Walker BR.
    Trends Endocrinol Metab; 2004 Nov 15; 15(9):418-24. PubMed ID: 15519888
    [Abstract] [Full Text] [Related]

  • 34. 11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus.
    Pereira CD, Azevedo I, Monteiro R, Martins MJ.
    Diabetes Obes Metab; 2012 Oct 15; 14(10):869-81. PubMed ID: 22321826
    [Abstract] [Full Text] [Related]

  • 35. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patents.
    Boyle CD, Kowalski TJ.
    Expert Opin Ther Pat; 2009 Jun 15; 19(6):801-25. PubMed ID: 19456274
    [Abstract] [Full Text] [Related]

  • 36. Coffee inhibits the reactivation of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: a glucocorticoid connection in the anti-diabetic action of coffee?
    Atanasov AG, Dzyakanchuk AA, Schweizer RA, Nashev LG, Maurer EM, Odermatt A.
    FEBS Lett; 2006 Jul 24; 580(17):4081-5. PubMed ID: 16814782
    [Abstract] [Full Text] [Related]

  • 37. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
    Jun YJ, Park SJ, Kim TH, Lee SH, Lee KJ, Hwang SM, Lee SH.
    J Allergy Clin Immunol; 2014 Oct 24; 134(4):926-934.e6. PubMed ID: 24810847
    [Abstract] [Full Text] [Related]

  • 38. Regulation of glucocorticoid sensitivity in thymocytes from burn-injured mice.
    D'Elia M, Patenaude J, Bernier J.
    Am J Physiol Endocrinol Metab; 2009 Jan 24; 296(1):E97-104. PubMed ID: 19001548
    [Abstract] [Full Text] [Related]

  • 39. Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species.
    Arampatzis S, Kadereit B, Schuster D, Balazs Z, Schweizer RA, Frey FJ, Langer T, Odermatt A.
    J Mol Endocrinol; 2005 Aug 24; 35(1):89-101. PubMed ID: 16087724
    [Abstract] [Full Text] [Related]

  • 40. Cortisone induces insulin resistance in C2C12 myotubes through activation of 11beta-hydroxysteroid dehydrogenase 1 and autocrinal regulation.
    Park SY, Bae JH, Cho YS.
    Cell Biochem Funct; 2014 Apr 24; 32(3):249-57. PubMed ID: 24122936
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 53.